Going to be .30+

Let's bring the golden cross baby!!! Bring it

Not to mention multi million in volume in a few weeks. Imo

If koos still owns bmsn, it wouldn't make any sense for him to kill and completely cut out bmsn. If he still owns bmsn. I'm a little worried as I own 90% bmsn and only 10% rgbp. Hope for the best for everyone. I appreciate your thoughts. Thank you.

I would if I could. Quit my cooking job yesterday and Headn back to finish college. Start in the fall. Long and could always be stronger.

I am much less invested into rgbp than I am Bmsn. I hadn't moved shares like many longs. I do want both to be successful obviously as rgbp makes Bmsn successful. Glta or most.

My hope is that the "go ahead" into clinical trials comes before the announcement of these two inds. I would think a greater impact to the pps would be a result compared to the other way around. We shall see!

In all "three" products? Or just hemaxellerate? Thought it was a singular deal and assumed mist thought dcellvax hasn't begun Charles river safety tests...? Maybe I've missed something. Could you care to explain. Thanks if you do.

My guess would be .01-.07.

Knowing who were dealing with id imagine late September to mid October, however my fingers are crossed for the go ahead. Good luck to all.

Safety test results from Charles river lab to fda. Concerning hemx.

Going back to .30 in two to three weeks. Imo

Lmao. I remember this being in a previous 10-q. Must have forgot to take it out. Funny part is if they did. Koos give up the grant!

That would be a very very bad thing. I don't see that happening. Fda won't stone wall us again.

Still have about 210k left to get us through September- October.

When great dd finds you! :p thanks.

Let's not forget the Zander 100k upfront and yearly. :) oh but what am I talking about...that will be ate up in minutes. lol

My faith is in regen, getting it done before bio has to resort to that. If news doesn't come along with the split entb is toast.

Not if bmsn goes like entb. That's were my most of my shares are at. If I could only go back in time.

Closer than ever. Put a g in bmsn and regen and wait for the ride. Been waiting three years for this and were in communications in this study with a third party. So it's either a yes or a no. My guess is yes!

A smart one. https://www.macabacus.com/restructuring/morris-trusts
So much can be gained.
The doctors we have..but you would know that as you were behind the stock for a short while.
Besides our cfo caven should have some interesting side advice for the man koos when he needs it.

Thank you again for your thoughts. Yea I saw something slightly mentioned on the updated regen site about flexus. I recall the deal back when it happened as well. Fingers crossed.

I'm sorry for being confused as I was away a bit before. You"re saying that dcellvax is already being tested in people?

I do remember your post where hemax is being tested in China. Or a simuliar drug like it. Or hemax completely? hmmm... Are both dcellvax and hemax being tested in people under the radar to better gauge the outcome, away from fda concern?!?

Thanks in advance..much appreciated.

Fda alone... We will see money. This company to be will be a actual company. Scientists. We have it in the bag.

Thank you!!!! My eyes are peeled and ready for that next s-8. I read these boards to learn and because of a few here...that is possible.

Should have kept my shares from a couple years ago...slaps face. Instead I kept them in the koos tri fecta which has yet to give back love. A guy can dream right.

Well there are no fans of him on that site. One comment. Come on koos!! Make us fans!

I was trying to find a connection between the doctors mentioned in this study in China to any known info about us. Unfortunately I was unsuccessful.

My largest hopes where that min took hemax to a country where the laws aren't as strict to get further in tests or trials.

I was imagining more of a chubby polar bear. :)

Min take it back to his people to do it right :)

It seems as if koos is doing something like a reverse morris trust. Here is a double one in the link. https://www.macabacus.com/strategies/double-rmt

Entb reverse merger to Zander. Fully granting Zander capital to give Regen; obviously noted in the pr"s.

We know Entb is being split but is it known that it's going to be a reverse merger into Zander or can we guess? What are your thoughts?

More models https://www.macabacus.com/strategies/morris-trust

Yes it seems so. Same concept as I can tell. I'm interested if you have any more knowledge of these other companies or what there names might be?( If you have time/Thanks in advance.) I like to compare drugs and share structures to our fellow little minnows. :)

I thought koos"s strategy was a bit unique however it makes me less worried if other companies have done the same and been successful.

VvAngelvV

These last few messages including yours are good thoughts and what matters now. Thank you for the reminders. Something soon has to happen. If it's Zander news with the split along with approval, all three tickets will run heavy.

I believe the tests will only be of better quality or near the same. Less toxins and less chance for cross contamination of foreign substances. Imo.

Hoping koos has a plan where everyone wins in this recent "fallout" activity of entb. If it's a ride along with news or just more shares for him to dilute.

Have a great fourth all! Have fun and be safe.

Ignorance is one thing. I didn't say it wasn't a great country. To say it is the "best" is the reason why wars happen in the first place.

I'm from the u.s. And it's a bit boastful to say that and mean it fully. Not everyone thinks this way. Rgbp

Or jail :)

Even though regen isnt connected to entb like Bmsn. They all, including entb will bounce heavily with hemax initiating trials.

Only thing on my mind is the glp studies. It's been 2 months and two weeks since choosing charles river.. Can't exactly remember the longest safety study that was a possibility in terms of weeks plus the given fda time to review...but we have to be close to seeing something in paper about that.